Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-066468
Filing Date
2014-11-04
Accepted
2014-11-04 21:27:30
Documents
2
Period of Report
2014-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 24502
2 EX-24 DOCUMENT attachment1.htm EX-24 2454
  Complete submission text file 0001209191-14-066468.txt   28319
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
ROBIN SHERRINGTON (Reporting) CIK: 0001619962 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 141194862